Drug Shortage Report for L-ARGININE HYDROCHLORIDE INJECTION

Last updated on 2022-05-06 History
Report ID 138151
Drug Identification Number 00399736
Brand name L-ARGININE HYDROCHLORIDE INJECTION
Common or Proper name L-ARGININE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ARGININE HYDROCHLORIDE
Strength(s) 250MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 30ML 1LIVI
ATC code V04CD
ATC description OTHER DIAGNOSTIC AGENTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2021-05-01
Actual start date
Estimated end date 2022-04-22
Actual end date 2022-05-05
Shortage status Resolved
Updated date 2022-05-06
Company comments Under allocation at 50% of historical usage.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-05-06 English Compare
v10 2022-05-05 French Compare
v9 2022-05-05 English Compare
v8 2022-04-06 French Compare
v7 2022-04-06 English Compare
v6 2022-02-04 French Compare
v5 2022-02-04 English Compare
v4 2021-05-02 English Compare
v3 2021-04-28 French Compare
v2 2021-04-28 English Compare
v1 2021-04-28 English Compare

Showing 1 to 11 of 11